Dupont Capital Management Corp Vbi Vaccines Inc Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$2.8 - $3.72 $229,658 - $305,118	-82,021 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$2.91 - $4.32 $48,949 - $72,666	-16,821 Reduced 17.02%	82,021 $255,000
Q4 2020 Jan 28, 2021	BUY	$2.15 - $3.5 $95,090 - $154,798	44,228 Added 80.98%	98,842 $272,000
Q3 2020 Oct 29, 2020	SELL	$2.77 - $6.17 $669,265 - $1.49 Million	-241,612 Reduced 81.56%	54,614 $156,000
Q2 2020 Jul 24, 2020	BUY	$0.87 - $3.13 $257,716 - $927,187	296,226 New	296,226 $918,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.